Tubac, Chrissel .

HRN: 29-20-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CEFUROXIME 1.5GM (VIAL)
06/20/2026
06/26/2026
IV
430MG
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: